Differentiating branch duct and mixed IPMN in endoscopically collected pancreatic cyst fluid via cytokine analysis

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Lee, Linda S ^a   Bellizzi, Andrew M ^b   Banks, Peter A ^a   Sainani, Nisha I ^a   Kadiyala, Vivek ^a   Suleiman, Shadeah ^a   Conwell, Darwin L ^a   Paulo, Joao A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOTAXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 9; LYMPHOTACTIN; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM; COMPARATIVE STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MIXED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM; PANCREAS CYST; PANCREAS JUICE; PROTEIN DETERMINATION;

EID: 84872792460     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/247309     Document Type: Article

References (57)

1. Lee L. S., Saltzman J. R., Bounds B. C., Poneros J. M., Brugge W. R., Thompson C. C., EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clinical Gastroenterology and Hepatology 2005 3 3 231 236 2-s2.0-17644374184 10.1016/S1542-3565(04)00618-4 (Pubitemid 40568728)
2. Al Haddad H., Laursen P. B., Chollet D., Ahmaidi S., Buchheit M., Reliability of resting and postexercise heart rate measures. International Journal of Sports Medicine 2011 32 8 598 605 2-s2.0-79961207302 10.1055/s-0031-1275356
3. Maker A. V., Lee L. S., Raut C. P., Clancy T. E., Swanson R. S., Cytology from pancreatic cysts has marginal utility in surgical decision-making. Annals of Surgical Oncology 2008 15 11 3187 3192 10.1245/s10434-008-0110-0
4. Cannon J. G., Inflammatory cytokines in nonpathological states. News in Physiological Sciences 2000 15 6 298 303 2-s2.0-0034556980
5. Fernandez E. J., Lolis E., Structure, function, and inhibition of chemokines. Annual Review of Pharmacology and Toxicology 2002 42 469 499 2-s2.0-0036178483 10.1146/annurev.pharmtox.42.091901.115838 (Pubitemid 34160533)
6. Rottman J. B., Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Veterinary Pathology 1999 36 5 357 367 2-s2.0-0033192591 (Pubitemid 129554584)
7. FitzGerald S. P., McConnell R. I., Huxley A., Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array. Journal of Proteome Research 2008 7 1 450 455 2-s2.0-38649142147 10.1021/pr070409o (Pubitemid 351171159)
8. Paulo J. A., Lee L. S., Wu B., Banks P. A., Steen H., Conwell D. L., Cytokine profiling of pancreatic fluid using the ePFT collection method in tandem with a multiplexed microarray assay. Journal of Immunological Methods 2011 369 1-2 98 107 2-s2.0-79958858198 10.1016/j.jim.2011.04.012
9. Sahani D. V., Sainani N. I., Blake M. A., Crippa S., Mino-Kenudson M., Fernandez Del-Castillo C., Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. American Journal of Roentgenology 2011 197 1 W53 W61 2-s2.0-79960484394 10.2214/AJR.10.5866
10. Kubo H., Chijiiwa Y., Akahoshi K., Hamada S., Harada N., Sumii T., Takashima M., Nawata H., Intraductal papillary-mucinous tumors of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology 2001 96 5 1429 1434 2-s2.0-0035008341 10.1016/S0002-9270(01)02357-7 (Pubitemid 32455070)
11. Hruban R. H., Takaori K., Klimstra D. S., Adsay N. V., Albores-Saavedra J., Biankin A. V., Biankin S. A., Compton C., Fukushima N., Furukawa T., Goggins M., Kato Y., Kloppel G., Longnecker D. S., Luttges J., Maitra A., Offerhaus G. J. A., Shimizu M., Yonezawa S., An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. American Journal of Surgical Pathology 2004 28 8 977 987 2-s2.0-3242744313 10.1097/01.pas.0000126675.59108.80 (Pubitemid 38971421)
12. Reid-Lombardo K. M., St Sauver J., Li Z., Ahrens W. A., Unni K. K., Que F. G., Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a Population Study. Pancreas 2008 37 2 139 144 2-s2.0-55949119935 10.1097/MPA.0b013e318162a10f
13. Paulo J. A., Lee L. S., Wu B., Repas K., Banks P. A., Conwell D. L., Steen H., Proteomic analysis of endoscopically (endoscopic pancreatic function test) collected gastroduodenal fluid using in-gel tryptic digestion followed by LC-MS/MS. Proteomics-Clinical Applications 2010 4 8-9 715 725 2-s2.0-78650477405 10.1002/prca.201000018
14. Paulo J. A., Lee L. S., Wu B., Repas K., Banks P. A., Conwell D. L., Steen H., Optimized sample preparation of endoscopic collected pancreatic fluid for SDS-PAGE analysis. Electrophoresis 2010 31 14 2377 2387 2-s2.0-77954713265 10.1002/elps.200900762
15. Paulo J. A., Lee L. S., Wu B., Repas K., Mortele K. J., Banks P. A., Steen H., Conwell D. L., Identification of pancreas-specific proteins in endoscopically (endoscopic pancreatic function test) collected pancreatic fluid with liquid chromatography-tandem mass spectrometry. Pancreas 2010 39 6 889 896 2-s2.0-77955186669 10.1097/MPA.0b013e3181cf16f4
16. Paulo J. A., Kadiyala V., Lee L. S., Banks P. A., Conwell D. L., Steen H., Proteomic analysis (gelc-ms/ms) of epft-collected pancreatic fluid in chronic pancreatitis. Journal of Proteome Research 2012 11 3 1897 1912 10.1021/pr2011022
17. Opalka D., Lachman C. E., MacMullen S. A., Jansen K. U., Smith J. F., Chirmule N., Esser M. T., Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clinical and Diagnostic Laboratory Immunology 2003 10 1 108 115 2-s2.0-0037246949 10.1128/CDLI.10.1.108- 115.2003 (Pubitemid 36133838)
18. Carson R. T., Vignali D. A. A., Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. Journal of Immunological Methods 1999 227 1-2 41 52 2-s2.0-0032856945 10.1016/S0022-1759(99)00069-1 (Pubitemid 29408703)
19. Sachdeva N., Asthana D., Cytokine quantitation: technologies and applications. Frontiers in Bioscience 2007 12 12 4682 4695 2-s2.0-34347225102 10.2741/2418
20. Vignali D. A. A., Multiplexed particle-based flow cytometric assays. Journal of Immunological Methods 2000 243 1-2 243 255 2-s2.0-0034699375 10.1016/S0022-1759(00)00238-6
21. Bender R., Lange S., Adjusting for multiple testing-when and how? Journal of Clinical Epidemiology 2001 54 4 343 349 2-s2.0-0035049158 10.1016/S0895-4356(00)00314-0 (Pubitemid 32303457)
22. Tanaka M., Chari S., Adsay V., Fernandez-del Castillo C., Falconi M., Shimizu M., Yamaguchi K., Yamao K., Matsuno S., International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006 6 1-2 17 32 2-s2.0-33646137556 10.1159/000090023
23. Tanaka M., Fernandez-del Castillo C., Adsay V., International consensus guidelines 2012 for the management of ipmn and mcn of the pancreas. Pancreatology 2012 12 3 183 197
24. Pedrosa I., Boparai D., Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World Journal of Gastrointestinal Surgery 2010 2 10 324 330 10.4240/wjgs.v2.i10.324
25. Shimizu K., Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. Journal of Gastroenterology 2008 43 11 823 832 2-s2.0-56649114152 10.1007/s00535-008-2249-7
26. Patel M., Fine D. R., Fibrogenesis in the pancreas after acinar cell injury. Scandinavian Journal of Surgery 2005 94 2 108 111 2-s2.0-23844553542 (Pubitemid 41169984)
27. Ellenrieder V., Schneiderhan W., Bachem M., Adler G., Fibrogenesis in the pancreas. Roczniki Akademii Medycznej w Bialymstoku 2004 49 40 46 2-s2.0-14644393802
28. Apte M. V., Wilson J. S., Mechanisms of pancreatic fibrosis. Digestive Diseases 2004 22 3 273 279 2-s2.0-16344384885 10.1159/000082799 (Pubitemid 40467602)
29. Masamune A., Kikuta K., Watanabe T., Satoh K., Hirota M., Hamada S., Shimosegawa T., Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009 58 4 550 559 2-s2.0-63849290925 10.1136/gut.2008.154401
30. Farrow B., Albo D., Berger D. H., The role of the tumor microenvironment in the progression of pancreatic cancer. Journal of Surgical Research 2008 149 2 319 328 2-s2.0-51049105755 10.1016/j.jss.2007.12.757
31. Aust S., Jäger W., Kirschner H., Klimpfinger M., Thalhammer T., Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1. Wiener Medizinische Wochenschrift 2008 158 19-20 575 578 2-s2.0-55949106478 10.1007/s10354-008-0599-7
32. Vonlaufen A., Apte M. V., Imhof B. A., Frossard J. L., The role of inflammatory and parenchymal cells in acute pancreatitis. Journal of Pathology 2007 213 3 239 248 2-s2.0-35948950822 10.1002/path.2231 (Pubitemid 350074013)
33. Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J., Apte M., Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002 50 4 535 541 2-s2.0-0036282292 10.1136/gut.50.4.535 (Pubitemid 34638875)
34. Apte M. V., Haber P. S., Darby S. J., Rodgers S. C., McCaughan G. W., Korsten M. A., Pirola R. C., Wilson J. S., Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999 44 4 534 541 2-s2.0-0032954505 (Pubitemid 29169954)
35. Preis M., Korc: M., Signaling pathways in pancreatic cancer. Critical Reviews in Eukaryotic Gene Expression 2011 21 2 115 129 10.1615/ CritRevEukarGeneExpr.v21.i2.20
36. Masamune A., Watanabe T., Kikuta K., Shimosegawa T., Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clinical Gastroenterology and Hepatology 2009 7 11 S48 S54 2-s2.0-71849097007 10.1016/j.cgh.2009.07.038
37. Shimizu K., Pancreatic stellate cells: molecular mechanism of pancreatic fibrosis. Journal of Gastroenterology and Hepatology 2008 23 supplement 1 S119 S121 2-s2.0-40749088538 10.1111/j.1440-1746.2007.05296.x (Pubitemid 351389042)
38. Jaster R., Emmrich J., Crucial role of fibrogenesis in pancreatic diseases. Best Practice and Research in Clinical Gastroenterology 2008 22 1 17 29 2-s2.0-38149070150 10.1016/j.bpg.2007.10.004
39. Blobe G. C., Schiemann W. P., Lodish H. F., Role of transforming growth factor β in human disease. New England Journal of Medicine 2000 342 18 1350 1358 2-s2.0-0034604110 10.1056/NEJM200005043421807 (Pubitemid 30408720)
40. Khalil N., TGF- β: from latent to active. Microbes and Infection 1999 1 15 1255 1263 2-s2.0-0033386176 10.1016/S1286-4579(99)00259-2 (Pubitemid 30020320)
41. Guo-Yang W. U., Qingjun L. U., Hasenberg T., Niedergethmann M., Post S., Sturm J. W., Keese M., Association between EGF, TGF- β l, TNF- α gene polymorphisms and cancer of the pancreatic head. Anticancer Research 2010 30 12 5257 5262 2-s2.0-78751520895
42. Chow J. Y. C., Ban M., Wu H. L., Nguyen F., Huang M., Chung H., Dong H., Carethers J. M., TGF- β downregulates PTEN via activation of NF- B in pancreatic cancer cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010 298 2 G275 G282 2-s2.0-76749088993 10.1152/ajpgi.00344. 2009
43. Truty M. J., Urrutia R., Basics of TGF- β and pancreatic cancer. Pancreatology 2007 7 5-6 423 435 2-s2.0-35348901453 10.1159/000108959 (Pubitemid 47587621)
44. Aoyagi Y., Oda T., Kinoshita T., Nakahashi C., Hasebe T., Ohkohchi N., Ochiai A., Overexpression of TGF- β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. British Journal of Cancer 2004 91 7 1316 1326 2-s2.0-6944242773 10.1038/sj.bjc.6602141 (Pubitemid 39424793)
45. Ellenrieder V., Buck A., Harth A., Jungert K., Buchholz M., Adler G., Urrutia R., Gress T. M., KLF11 mediates a critical mechanism in TGF- β signaling that is inactivated by ERK-MAPK in pancreatic cancer cells. Gastroenterology 2004 127 2 607 620 2-s2.0-4143069155 10.1053/j.gastro.2004.05. 018 (Pubitemid 39091908)
46. Teraoka H., Sawada T., Yamashita Y., Nakata B., Ohira M., Ishikawa T., Nishino H., Hirakawa K., TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion. International Journal of Oncology 2001 19 4 709 715 2-s2.0-0035486830
47. Ellenrieder V., Hendler S. F., Ruhland C., Boeck W., Adler G., Gress T. M., TGF- β -induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. International Journal of Cancer 2001 93 2 204 211 2-s2.0-0035879867 10.1002/ijc.1330 (Pubitemid 32574276)
48. Kleeff J., Ishiwata T., Maruyama H., Friess H., Truong P., Büchler M. W., Falb D., Korc M., The TGF- β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 1999 18 39 5363 5372 2-s2.0-0033598408 10.1038/sj.onc.1202909 (Pubitemid 29469224)
49. Zavoral M., Minarikova P., Zavada F., Salek C., Minarik M., Molecular biology of pancreatic cancer. World Journal of Gastroenterology 2011 17 24 2897 2908 2-s2.0-79959669594 10.3748/wjg.v17.i24.2897
50. Groblewska M., Mroczko B., Wereszczynska-Siemiatkowska U., Mysliwiec P., Kedra B., Szmitkowski M., Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clinical Chemistry and Laboratory Medicine 2007 45 1 30 34 2-s2.0-33846559860 10.1515/CCLM.2007.025 (Pubitemid 46155556)
51. Joshita S., Nakazawa K., Sugiyama Y., Kamijo A., Matsubayashi K., Miyabayashi H., Furuta K., Kitano K., Kawa S., Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Internal Medicine 2009 48 9 687 691 2-s2.0-67650084328 10.2169/internalmedicine.48.1900
52. Ohtsubo K., Mouri H., Sakai J., Akasofu M., Yamaguchi Y., Watanabe H., Gabata T., Motoo Y., Okai T., Sawabu N., Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry. Journal of Clinical Gastroenterology 1998 27 4 357 360 2-s2.0-0031763494 10.1097/00004836-199812000-00018 (Pubitemid 28547480)
53. Wiekowski M. T., Leach M. W., Evans E. W., Sullivan L., Chen S. C., Vassileva G., Bazan J. F., Gorman D. M., Kastelein R. A., Narula S., Lira S. A., Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. Journal of Immunology 2001 166 12 7563 7570 2-s2.0-0035877257 (Pubitemid 32525637)
54. Langowski J. L., Zhang X., Wu L., Mattson J. D., Chen T., Smith K., Basham B., McClanahan T., Kastelein R. A., Oft M., IL-23 promotes tumour incidence and growth. Nature 2006 442 7101 461 465 2-s2.0-33746534417 10.1038/nature04808 (Pubitemid 44264796)
55. Barreiro O., Yáñez-Mó M., Serrador J. M., Montoya M. C., Vicente-Manzanares M., Tejedor R., Furthmayr H., Sánchez-Madrid F., Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. Journal of Cell Biology 2002 157 7 1233 1245 2-s2.0-0037166942 10.1083/jcb.200112126 (Pubitemid 34847793)
56. Kleinhans H., Kaifi J. T., Mann O., Reinknecht F., Freitag M., Hansen B., Schurr P. G., Izbicki J. R., Strate T. G., The role of vascular adhesion molecules PECAM-1 (CD 31), VCAM-1 (CD 106), E-selectin (CD62E) and P-selectin (CD62P) in severe porcine pancreatitis. Histology and Histopathology 2009 24 5 551 557 2-s2.0-67149111804
57. Pollard H. B., Srivastava M., Eidelman O., Jozwik C., Rothwell S. W., Mueller G. P., Jacobowitz D. M., Darling T., Guggino W. B., Wright J., Zeitlin P. L., Paweletz C. P., Protein microarray platforms for clinical proteomics. Proteomics-Clinical Applications 2007 1 9 934 952 2-s2.0-38349101934 10.1002/prca.200700154